With backing from Bayer, a London firm will pitch its ‘hospitals at home’ concept for decentralized trials – Endpoints News
CONTEXT: Increased backing for the post-COVID era decentralised clinical trials. Can’t help thinking that this feels like a dot com bubble that will burst when the first major safety concerns Continue Reading